| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| GRUPO ONCOCLINICAS Aktie jetzt für 0€ handeln | |||||
| Di | Oncoclínicas Q2 2026 slides: cash flow rebounds amid supply crisis | 1 | Investing.com | ||
| 11.08. | São Paulo police target two Goldman executives in Oncoclínicas case | 2 | Valor International | ||
| 11.08. | Brazilian police accuse Goldman executives of fraud over Oncoclinicas tender offer | 4 | Reuters | ||
| 10.08. | Brazil audit court probes alleged conflicts in Oncoclínicas offering | 2 | Valor International | ||
| 23.07. | Goldman Sachs exits Oncoclínicas after 11 years | 2 | Valor International | ||
| 20.07. | IG4 seeks control of Oncoclínicas as Centaurus cuts stake | 1 | Valor International | ||
| 14.07. | Oncoclínicas files for out-of-court restructuring of R$5.1bn debt | 2 | Valor International | ||
| 08.07. | Oncoclínicas will seek out-of-court restructuring of R$4bn debt | 1 | Valor International | ||
| 19.06. | Oncoclínicas nears out-of-court debt restructuring deal | 3 | Valor International | ||
| 17.04. | Court grants Oncoclínicas temporary protection from creditors | 1 | Valor International | ||
| 14.04. | Porto and Fleury drop bid for Oncoclínicas | 3 | Valor International | ||
| 13.04. | Oncoclínicas seeks court protection from creditors | 1 | Valor International | ||
| 10.04. | Oncoclínicas 4Q25 slides show margin recovery amid revenue reset | 2 | Investing.com | ||
| 08.04. | Oncoclínicas expected to seek court protection from creditors | 1 | Valor International | ||
| 07.04. | Oncoclínicas races to secure funding as liquidity tightens | 2 | Valor International | ||
| 25.03. | U.S. investor pushes for board shake-up in Oncoclínicas rescue bid | 1 | Valor International | ||
| 24.03. | Fleury, Porto propose breakup and restructuring of Oncoclínicas | 1 | Valor International | ||
| 23.03. | Fleury, Porto plan Oncoclínicas clinics deal | 1 | Valor International | ||
| 12.03. | Oncoclínicas negotiates debt restructuring after rating cuts | 1 | Valor International | ||
| 06.03. | Oncoclínicas hires new CEO to help oversee restructuring | 1 | Valor International |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 40,140 | -1,83 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 46,600 | +0,83 % | PRESSESPIEGEL/Unternehmen: PORSCHE, FRANKFURTER LEBEN/DWS, FRESENIUS KABI, ANTHROPIC, LEGORA | DJ PRESSESPIEGEL/Unternehmen
Die wirtschaftsrelevanten Themen aus den Medien, zusammengestellt von Dow Jones Newswires.
PORSCHE - Der Sportwagenbauer Porsche plant nach Informationen der Wirtschaftswoche... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 40,200 | +0,98 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| HEARTFLOW | 50,33 | +7,54 % | Heartflow Aktie auf Rekordhoch: Kurs steigt auf 48,7 USD | ||
| AVEANNA HEALTHCARE | 13,385 | +3,20 % | Biotech Stocks At 52-Week Highs - PARK +10%, AVAH +24%, CADL +10% On Q2 Reports, LH, COAG | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 32,480 | +1,06 % | Milliardenmarkt Augengesundheit: Warum EssilorLuxottica und Carl Zeiss Meditec auf neue Technologien setzen - und wo Rise Nano Optics ins Spiel kommt | ||
| BRIGHTSPRING HEALTH SERVICES | 59,45 | -0,14 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| BILLIONTOONE | 96,75 | +1,55 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| GENEDX | 84,35 | +2,18 % | GeneDx launches online exome testing for pediatric patients | ||
| PROGYNY | 25,490 | -1,81 % | Progyny, Inc. Announces Second Quarter 2026 Results | Reports Record Quarterly Revenue, Gross Profit and Adjusted EBITDARobust Selling Season Activity Continues to Reflect Strong Demand for Women's Health, Family Building SolutionsValue Returned to Shareholders... ► Artikel lesen | |
| SANARA MEDTECH | 34,290 | +0,15 % | Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) | FORT WORTH, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," "Sanara MedTech," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology company focused on developing... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 13,100 | +1,31 % | Alignment Healthcare files motion to dismiss whistleblower lawsuit | ||
| LIFESTANCE HEALTH GROUP | 12,560 | -0,71 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| DRAEGERWERK | 110,80 | +0,36 % | dpa-AFX-Überblick: UNTERNEHMEN vom 10.08.2026 - 15.15 Uhr | ROUNDUP: Hypoport bestätigt Jahresziele für 2026 - Aktie legt zu BERLIN - Der Finanzdienstleister Hypoport sieht sich auf Kurs zu seinen Jahreszielen. "Die geopolitischen Spannungen des ersten Halbjahres... ► Artikel lesen | |
| GERRESHEIMER | 27,600 | +1,40 % | Gerresheimer-Aktie: Nochmals Schwung holen für +30%? | Die Gerresheimer-Aktie verharrt seit Wochen in einer Konsolidierung unmittelbar unterhalb des entscheidenden Widerstands bei 29,56 €. In meiner vorherigen Analyse standen oberhalb von 30 € noch rund... ► Artikel lesen |